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Sir,
The Eye and Adenocarcinoma of the Breast:
Metastases and Meningiomas
There have now been a number of reports high lighting the association between adenocarcinoma of the breast and meningioma. 1 -3 Breast cancer is the commonest fatal malignant neoplasm of women, 4 and meningioma is one of the commoner intracrttnial tumours, accounting for 19% of all central nervous system tumours ? Carcinoma of the breast is also the second commonest source of intracranial metastases (after carcinoma of the bronchus) 3 and the most frequent source of choroidal metastases. 5 , 6 We present a patient with advanced carcinoma of the breast whose signs of intracranial mass with cranial nerve involvement were initially ascribed to a metastasis but subsequently found to be due to a meningioma. Detailed ophthalmic examination revealed the presence of an associated choroidal metastasis.
Case Report
A 71-year-old woman with known disseminated adenocarcinoma of the breast was referred to the eye unit by the radiotherapy department with a short history of diplopia. She had initially presented S years earlier with a large fungating tumour of the right breast and had subsequently received several courses of chemotherapy and radiotherapy for her metastatic disease, which included multiple bony secondaries and malignant pleural and pericardial effusions. Her initial symptoms consisted of migrainous headaches in the morning, 'trouble focusing' and photopsia in the left eye. Two weeks later she developed diplopia on upgaze and was referred for ophthalmic assessment. Her vision was 6/6 in both eyes but she had a mild left ptosis, an enlarged and unresponsive left pupil and a small left hypo tropia (7 Ll) and exotropia (SLl). Elevation of the left eye was limited, particularly in abduction. A Hess chart confirmed this and also revealed a small limitation of adduction supporting the clinical diagnosis of a partial third nerve palsy (Fig. 1) . On dilated funduscopy, a pale elevated lesion approximately 3 disc diameters in size with indistinct borders was noted inferonasal to the optic disc in the left eye (Fig. 2) . Fluorescein angiography (Fig. 3) showed a diffuse leak and this lesion was thought to be a choroidal metastatic deposit with an overlying serous retinal detachment.
An initial computed tomography (CT) scan of the head revealed a suspicious area adjacent to the pituitary which was thought to represent a secondary deposit. However, whilst the bone scan showed secondaries in the vault, there were no 'hot-spots' ; in the orbit or base of the skull. Therefore, a repeat CT scan with contrast was performed which showed a well-defined, hyperdense mass which enhanced uniformly, characteristic of a meningioma of the right sphenoidal ridge (Figs. 4, 5) .
Soon after the onset of diplopia, the patient also required decarubicin and then 3-M (mitomycin C, mitosantrone and methotrexate) chemotherapy as well as radiotherapy for progressive local and metastatic breast carcinoma. In the ensuing months her ophthalmoplegia remained stable and her ocular symptoms were satisfactorily controlled by a Fresnel prism alone. During this time there was no clinically obvious progression of the left choroidal metastasis. Unfortunately, her general condition continued to deteriorate and she died in a hospice 19 months after the onset of her eye problems.
Discussion
The unusually high rate of coexistence of breast carcinoma and intracranial meningioma was first reported by Schoenberg et ai. in 1975 1 and since then a number of case reports have supported this, z , 3 , 7 -9 It has been postulated that the link between the two neoplasms is a sensitivity to female sex hormones. The risk of developing breast cancer is known to be influenced by circulating levels of free oestradiol 1o and the presence of active oestrogen receptors is used as a guide to the likely responsiveness of the tumour to hormonal therapy. ll
There are a number of persuasive reasons to believe that meningiomas are under hormonal influence. There is a female preponderance (women constitute two-thirds of patients with intracranial meningiomas) 2 , 12 and there are several published reports of the symptoms and the size of meningiomas being reversibly increased in preg nancy and during the follicular phase of the menstrual cycleP-15 The risk of meningioma is reduced in postmenopausal women l6 but is increased in severe obesity where oestrogen levels are raised. 11 Finally, the presence of oestrogen and progesterone rece � tors within tumour tissue has been documented 1,12 and there is preliminary evidence that hormonal therapy may be helpful in the treatment of meningiomasP However, this theory is by no means universally accepted as there is evidence that the changes in meningioma size in pregnancy are related to alterations in water content or vascularity rather than a true increase in tumour mass. 15 In addition, many studies have failed to show significant oestrogen receptor numbers and activity in meningioma tissue 18 , 1 9 or any growth modulation with hormonal treatment. 20 This case illustrates several important issues in the investigation and management of neurological or visual symptoms in patients with a history of carcinoma of the breast. Firstly, the assumption that an intracranial mass lesion equates with a LEITERS TO THE JOURNAL cerebral secondary may not always be correct, particularly if there is no other evidence of disseminated carcinoma. Relatively benign or treat able space-occupying lesions, such as chronic sub dural haematoma and astrocytoma, 8 as well as meningioma, need to be excluded by investigations such as CT with contrast, angiography and magnetic resonance imaging (MRI). Meningiomas have a characteristic appearance on CT, being well defined, high-density and homogeneously enhancing lesions found in characteristic locations, whereas metastases show poor definition, low density, marked perilesional oedema and non-homogeneous enhancement. 9 Meningiomas are potentially curable by surgery alone and may not be responsive to the radiotherapy which would be instigated for the treatment of metastases. 21 It should be noted that the appearance of mUltiple intracranial masses does not exclude the diagnosis of coexistent meningiomata since they are multiple in 10% of cases?
Secondly, patients with a history of neoplastic disease, particularly of the breast or bronchus, who develop visual symptoms should have a complete ophthalmic examination. In this particular case, an assessment of the ocular motility alone would have missed the choroidal metastasis. In retrospect the history of photopsia before the onset of diplopia may have been caused by the choroidal lesion and perhaps should have prompted an earlier ophthal mological referral, although the outcome would not have been affected in this patient. A high index of suspicion coupled with a thorough ophthalmic examination including dilated funduscopy may reveal choroidal secondaries which can be the first sign of disseminated diseases 6 ,22 and indeed may even be noted before the primary tumour is diagnosed.2 3 ,2 4 Choroidal metastases are usually radiosensitive and palliative treatment can improve the vision by shrinking the lesion and promoting absorption of subretinal fluid? 4 ,25 Such treatment may prevent further ophthalmic complications and improve the patient's quality of life during a terminal illness.
